<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee180394c55">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2002-09-20</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-02-445</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-02-445</identifier>
<identifier type="local">P0b002ee180394c55</identifier>
<identifier type="former package identifier">f:d02445</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-02-445</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-02-445</accessId>
 <reportNumber>GAO-02-445</reportNumber>
 <subject>Aircraft pilots</subject>
 <subject>Biological warfare</subject>
 <subject>Chemical and biological agents</subject>
 <subject>Emergency preparedness</subject>
 <subject>Health care planning</subject>
 <subject>Health care services</subject>
 <subject>Health hazards</subject>
 <subject>Immunization programs</subject>
 <subject>Immunization services</subject>
 <subject>Infectious diseases</subject>
 <subject>Military reserve personnel</subject>
 <subject>National Guard</subject>
 <subject>Safety</subject>
 <subject>Surveys</subject>
 <subject>CDC/FDA Vaccine Adverse Events Reporting</subject>
 <subject>System</subject>
 <type>Other Written Product</type>
 <accountNo>A05107</accountNo>
</extension>
<titleInfo>
 <title>Anthrax Vaccine: GAO&apos;s Survey of Guard and Reserve Pilots and Aircrew</title>
</titleInfo>
<abstract>GAO reviewed the views of pilots and aircrew members of the Air
National Guard and Air Force Reserve regarding the Anthrax	 
Vaccine Immunization Program (AVIP) of the Department of Defense 
(DOD). In December 1997, the Secretary of Defense announced a	 
plan to inoculate U.S. forces against the potential battlefield  
use of anthrax as a biological warfare (BW) agent. In the context
of the conventional battlefield, the nature and magnitude of the 
military BW threat has not changed materially since 1990 in terms
of the number of countries suspected of developing BW capability,
the types of BW agents they possess, or their ability to	 
weaponize and deliver BW agents. In marked contrast to other	 
mandatory DOD immunization requirements, GAO&apos;s sample survey in  
2000 showed that AVIP was at that time adversely affecting the	 
retention of trained and experienced guard and reserve pilots and
aircrew members. Between September 1998 and September 2000, 16	 
percent of the pilots and aircrew members of the guard and	 
reserve had (1) transferred to another unit (primarily to	 
nonflying positions to avoid or delay receiving the anthrax	 
shots), (2) moved to inactive status, or (3) left the military.  
Additionally, one in five of those still participating in or	 
assigned to a unit in 2000 indicated their intention to leave in 
the near future. At the time of the survey, two-thirds of the	 
guard and reserve pilots and aircrew members did not support	 
DOD&apos;s mandatory AVIP or any future immunization programs planned 
for other BW agents. However, these negative views did not appear
to indicate a general antivaccine bias. On the basis of the	 
survey, GAO estimated that 37 percent of the guard and reserve	 
pilots and aircrew members had received one or more anthrax shots
as of September 2000. Of these recipients, 85 percent reported	 
experiencing some type of reaction. This overall rate reported	 
for adverse reactions following anthrax immunization was more	 
than double the rate published in the vaccine manufacturer&apos;s	 
product insert that was in use at the time of the survey.	 
Respondents to the survey indicated that they had not reported	 
most of the reactions they cited to the military chain of command
through official or informal channels and that they were not	 
reported to Food and Drug Administration&apos;s Vaccine Adverse Events
Reporting System (VAERS). Reasons survey respondents gave for not
reporting to the military chain of command included a lack of	 
awareness of VAERS, a concern about the loss of flight status, a 
possibly adverse effect on military or civilian career, and a	 
fear of ridicule.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-02-445/html/GAOREPORTS-GAO-02-445.htm</url>
</location>
<identifier type="preferred citation">GAO-02-445</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-02-445</url>
</location>
<note>Other Written Product</note>
<extension>
 <searchTitle>GAO-02-445; Anthrax Vaccine: GAO&apos;s Survey of Guard and Reserve Pilots and Aircrew;
            </searchTitle>
</extension>
<subject>
 <topic>Aircraft pilots</topic>
 <topic>Biological warfare</topic>
 <topic>Chemical and biological agents</topic>
 <topic>Emergency preparedness</topic>
 <topic>Health care planning</topic>
 <topic>Health care services</topic>
 <topic>Health hazards</topic>
 <topic>Immunization programs</topic>
 <topic>Immunization services</topic>
 <topic>Infectious diseases</topic>
 <topic>Military reserve personnel</topic>
 <topic>National Guard</topic>
 <topic>Safety</topic>
 <topic>Surveys</topic>
 <topic>CDC/FDA Vaccine Adverse Events Reporting</topic>
 <topic>System</topic>
</subject>
</mods>